Photobiomodulation in Pulmonary Fibrosis post Covid-19
Not Applicable
Recruiting
- Conditions
- pulmonary fibrosisC01.748.610.763.500
- Registration Number
- RBR-7csg79n
- Lead Sponsor
- Centro Universitário de Itajubá
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with post-COVID-19 pulmonary fibrosis; aged between 51 and 81 years; both genders
Exclusion Criteria
Patients with thromboembolic alterations such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism; tracheostomized; with a body mass index (BMI) >29.9 kgm2; who had neoplasms; history of photosensitivity; who had previously undergone Cardiopulmonary rehabilitation
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected that the photobiomodulation technique with low-intensity light, using near-infrared LEDs, in association with cardiopulmonary rehabilitation through aerobic exercises, will be effective in the treatment of patients with post-COVID-19 pulmonary fibrosis
- Secondary Outcome Measures
Name Time Method A positive effect of LED therapy on the lung function of post-COVID-19 patients is expected, in addition to the resulting improvement in respiratory muscle performance, through the analysis of Maximum Inspiratory Pressure (MIP) and Maximum Expiratory Pressure (MEP) and better performance cardiopulmonary by means of the distance covered in the 6MWT. We will find improvement in cardiopulmonary capacity through the Functional Status Scale (PCFS) and better clinical recovery of the patient through verification of pulse oximetry and complaint of dyspnea on exertion